| Insider | Title | Company | Date | Price | Return | Shares | Value |
|---|---|---|---|---|---|---|---|
| Murphy Sean | Chief Manuf, Strategy | TriSalus Life Sciences, Inc. (TLSI) | 2025-01-28 | $5.24 | 0.0% | 30,000 | $157,200 |
| Murphy Sean | Non-Executive Director | Poseida Therapeutics, Inc. (PSTX) | 2020-07-14 | $16.00 | -83.1% | 10,000 | $160,000 |
| Return | Profit / (loss) | Cost | |||||
| Total | -41.9% | $-132,900 | $317,200 |